52 /100
HIGH RISK
Score updated May 30, 2026

EKSO — Ekso Bionics Holdings Inc Dilution Risk Tracker

Track EKSO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EKSO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
30%
📉 Score Deterioration 40%
• Score rose 30 points recently (worsening)
💰 Capital Raise 35%
• Low cash runway: 3 months remaining
🔔 Track EKSO — Get forecast alerts →

💹 Market Data

Market Cap$42.05M
Shares Outstanding3.56M
Float2.24M
Cash$1.17M
Debt$4.64M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 15.4% shares (2025Q4 vs prior)
28 institutional holders · 297.6K shares
#1 DBA TRADING, LLC 156.8K shares
#2 Cresset Asset Management, LLC 53.9K shares
#3 VANGUARD GROUP INC 35.5K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest180.5K
Days to Cover4.9
% of Float8.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2015
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track EKSO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EKSO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for EKSO
📊 EKSO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EKSO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.